Immuron (IMRN) vs Jaguar Health (JAGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Immuron is the larger company by market cap ($9.0 million vs $8.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMRN | JAGX |
|---|---|---|
| Share price | $1.11 | $4.53 |
| Market cap | $8.96M | $8.81M |
| 1-day change | +1.83% | -9.40% |
| EPS (TTM) | $-0.34 | $-4,012.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.39 | $1,267.88 |
| 52-week low | $0.677 | $2.35 |
| Distance from 52-week high | -53.56% | -99.64% |
| Analyst consensus | none | — |
| Avg. price target upside | +250.45% | — |
| Average volume | 2.06M | 2.00M |
| Shares outstanding | 8.07M | 1.95M |
| Employees | 7 | 47 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Immuron
IMRN stock →Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products.
Healthcare · Biotechnology · 7 employees
About Jaguar Health
JAGX stock →Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health.
Healthcare · Biotechnology · 47 employees
IMRN vs JAGX FAQ
Which is bigger, Immuron or Jaguar Health?
Immuron (IMRN) is larger, with a market capitalization of $8.96M compared with $8.81M for Jaguar Health (JAGX).
Are Immuron and Jaguar Health in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.